Instructor in Medicine, Massachusetts General Hospital
BIOGRAPHY
JUL 07, 2020 9:00 AM PDT
Mass cytometry in vaccine development: utility and considerations
Presented at:
Fluidigm Infectious Disease and Oncology Virtual Summit
Speaker
Abstract
This presentation will discuss how mass cytometry can benefit vaccine research programs to overcome hurdles, deliver valuable insights and inform the evaluation of candidate vaccines. Results and lessons from the development of a novel vaccine for Coxiella burnetii and other examples will illustrate key benefits, challenge, and considerations for integrating mass cytometry into vaccine research programs.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
MAY 29, 2024 | 9:00 AM
C.E. CREDITS
Histology laboratorians in the research world move fast, but those who perform cryosectioning know that these particular tissues require lighting speed and precision. Cryosectioning is the a...
MAY 29, 2024 | 8:00 AM
A-TEEM spectroscopy is an emerging technique with huge potential for QC laboratories in the pharmaceutical and biopharmaceutical industries. We present a set of tools for A-TEEM spectroscopy...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
Loading Comments...